USD 15.63
(4.73%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 174.45 Million USD | 0.62% |
2022 | 173.37 Million USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 181.45 Million USD | 4.01% |
2024 Q2 | 192.24 Million USD | 5.95% |
2023 FY | 174.45 Million USD | 0.62% |
2023 Q1 | 170.63 Million USD | -1.58% |
2023 Q2 | 170.34 Million USD | -0.17% |
2023 Q4 | 174.45 Million USD | 2.51% |
2023 Q3 | 170.18 Million USD | -0.1% |
2022 Q1 | 151.34 Million USD | 0.0% |
2022 FY | 173.37 Million USD | 0.0% |
2022 Q4 | 173.37 Million USD | 0.14% |
2022 Q3 | 173.13 Million USD | 9.25% |
2022 Q2 | 158.47 Million USD | 4.71% |
2021 Q3 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Alcon Inc. | 5.14 Billion USD | 96.608% |
AptarGroup, Inc. | 1.18 Billion USD | 85.274% |
Baxter International Inc. | 14.36 Billion USD | 98.785% |
Becton, Dickinson and Company | 15.87 Billion USD | 98.901% |
Bausch + Lomb Corporation | 4.56 Billion USD | 96.176% |
Haemonetics Corporation | 873.88 Million USD | 80.037% |
Envista Holdings Corp | 1.65 Billion USD | 89.45% |
ResMed Inc. | 873.93 Million USD | 80.038% |
Teleflex Incorporated | 1.92 Billion USD | 90.944% |
West Pharmaceutical Services, Inc. | 309 Million USD | 43.541% |